Literature DB >> 22313865

Glycodelin-A interferes with IL-2/IL-2R signalling to induce cell growth arrest, loss of effector functions and apoptosis in T-lymphocytes.

Chetna Soni1, Anjali A Karande.   

Abstract

BACKGROUND: The progesterone-regulated glycoprotein glycodelin-A (GdA), secreted by the decidualized endometrium at high concentrations in primates, inhibits the maternal immune response against fetal antigens and thereby contributes to the tolerance of the semi-allogenic fetus during a normal pregnancy. Our earlier studies demonstrated the ability of GdA to induce an intrinsic apoptotic cascade in CD4(+) T-lymphocytes and suppress the cytolytic effector function of CD8(+) T-lymphocytes. In this report, we investigated further into the mechanism of action of GdA controlling perforin and granzyme B expression in CD8(+) T-lymphocytes and the mechanism of action of GdA leading to lymphocyte death.
METHODS: Flow cytometry analysis was performed to check for the surface expression of interleukin-2 receptor α (IL-2Rα) and intracellular eomesodermin (Eomes) in activated T-lymphocytes, whereas quantitative RT-PCR analysis was used to find out their mRNA profile upon GdA treatment. Western analysis was carried out to confirm the protein level of Bax and Bcl-2.
RESULTS: GdA reduces the surface expression of the high-affinity IL-2R complex by down-regulating the synthesis of IL-2Rα (CD25). This disturbs the optimal IL-2 signalling and decreases the Eomes expression, which along with IL-2 directly regulates perforin and granzymes expression. Consequently, the CD8(+) T-lymphocytes undergo growth arrest and are unable to mature into competent cytotoxic T-lymphocytes. In the CD4(+) T-lymphocytes, growth factor IL-2 deprivation leads to proliferation inhibition, decreased Bcl-2/enhanced Bax expression, culminating in mitochondrial stress and cell death.
CONCLUSIONS: GdA spurs cell cycle arrest, loss of effector functions and apoptosis in different T-cell subsets by making T-lymphocytes unable to respond to IL-2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313865     DOI: 10.1093/humrep/der477

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Immunomodulatory activity of glycodelin: implications in allograft rejection.

Authors:  A Dixit; B Balakrishnan; A A Karande
Journal:  Clin Exp Immunol       Date:  2018-01-18       Impact factor: 4.330

Review 2.  The Roles of Glycodelin in Cancer Development and Progression.

Authors:  Juan Cui; Yanguo Liu; Xiuwen Wang
Journal:  Front Immunol       Date:  2017-11-29       Impact factor: 7.561

3.  Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma.

Authors:  Marc A Schneider; Thomas Muley; Nicolas C Kahn; Arne Warth; Michael Thomas; Felix J F Herth; Hendrik Dienemann; Michael Meister
Journal:  Oncotarget       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.